Affiliation: University of California
- Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery?Fernando Velayos
Center for Colitis and Crohn s Disease, University of California, San Francisco, California 94118, USA
Clin Gastroenterol Hepatol 5:668-71. 2007
- Positioning biologic therapy for Crohn's disease and ulcerative colitisFernando S Velayos
Center for Crohn s and Colitis, University of California, San Francisco, 2330 Post Street Suite 610, San Francisco, California 94115, USA
Curr Gastroenterol Rep 9:521-7. 2007....
- A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximabFernando S Velayos
Division of Gastroenterology and Hepatology, University of California, San Francisco, California 94115, USA
Clin Gastroenterol Hepatol 11:654-66. 2013..The comparative cost effectiveness of these 2 strategies is unknown. We investigated whether a testing-based strategy is more cost effective than an empiric dose-escalation strategy...
- Managing risks of neoplasia in inflammatory bowel diseaseFernando Velayos
University of California, San Francisco, Center for Crohn s and Colitis, San Francisco, CA 94115, USA
Curr Gastroenterol Rep 14:174-80. 2012..Physicians and health professionals may find this information useful for counseling and educating patients as well as for improving patient care...
- Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practicesFernando Velayos
University of California, San Francisco, Center for Crohn s and Colitis, 2330 Post Street, Suite 610, San Francisco, CA 94116, USA
Expert Rev Gastroenterol Hepatol 2:817-25. 2008..This article reviews the current practice and emerging technologies for detecting and preventing colon cancer in patients with IBD...
- Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery systemFernando S Velayos
Division of Gastroenterology, Department of Internal Medicine, University of California, San Francisco 94115, USA
Gastroenterology 139:1511-8. 2010..Limited data are available on rates of colonoscopy surveillance and factors associated with surveillance...
- Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitisBrindusa Truta
99 Lupine Ave, 503, San Francisco, CA, 94118, USA
Dig Dis Sci 59:135-45. 2014..One of the causes of pouch failure after ileal pouch anal anastomosis (IPAA) for ulcerative colitis (UC) is the development of de novo Crohn's disease (CD). Our aim was to clearly define factors associated with post-IPAA CD...
- Colonoscopy after CT diagnosis of diverticulitis to exclude colon cancer: a systematic literature reviewVictor F Sai
Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143, USA
Radiology 263:383-90. 2012..To estimate the prevalence of underlying adenocarcinoma of the colon in patients in whom acute diverticulitis was diagnosed at computed tomography (CT) and to compare that to the prevalence of colon cancer in the general population...
- Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylatesJoel H Rubenstein
The Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA
Am J Gastroenterol 104:2222-32. 2009..Therefore, in patients prescribed 5-ASAs for maintenance of remission, annual surveillance might be overly burdensome and inefficient. We aimed to determine the ideal frequency of surveillance in patients with UC maintained on 5-ASAs...
- Colorectal cancer screening and surveillance in the elderly patientLukejohn W Day
Division of Gastroenterology, San Francisco General Hospital, San Francisco, California, USA
Am J Gastroenterol 106:1197-206;quiz 1207. 2011..This review addresses the factors unique to colorectal cancer and performing colonoscopy in older adults that are relevant in weighing the risks and benefits of screening and surveillance in this population...
- Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's diseaseFernando S Velayos
Division of Gastroenterology and Hepatology, University of California, San Francisco, California, USA
Inflamm Bowel Dis 10:657-60. 2004..Postmarketing surveillance through June of 2001 has identified 10 cases of PCP occurring during treatment with infliximab; 3 patients died...
- Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control studyFernando S Velayos
Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco, California, USA
Gastroenterology 130:1941-9. 2006..The presence of postinflammatory pseudopolyps and use of other anti-inflammatory medications may be important variables that influence risk, but data are sparse...
- Challenges in designing a national surveillance program for inflammatory bowel disease in the United StatesMillie D Long
1Division of Gastroenterology and Hepatology, Departments of Medicine and Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 2Johns Hopkins University School of Medicine, Baltimore, Maryland 3Center for Crohn s and Colitis, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 4Department of Community Health Sciences, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada 5Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada 6Icahn School of Medicine at Mount Sinai, New York, New York 7Epimad Registry, Epidemiology Unit, Hospital and University Lille Nord de France, Lille, France 8Kaiser Permanente Northern California, Oakland, California 9UCSF Center for Colitis and Crohn s Disease, University of California, San Francisco, San Francisco, California 10Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 11Mount Sinai Hospital Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, Canada 12Portland VA Medical Center, Portland, Oregon 13Alpert Medical School of Brown University, Providence, Rhode Island 14RTI Health Solutions, Research Triangle Institute, Research Triangle Park, North Carolina 15Department of Epidemiology, Boston University School of Public Health, Boston, Harvard University
Inflamm Bowel Dis 20:398-415. 2014..This new model should focus on "surveillance of the burden of disease," including (1) natural history of disease and (2) outcomes and complications of the disease and/or treatments...
- Colorectal cancer and the elderlyLukejohn W Day
Division of Gastroenterology, Department of Medicine, San Francisco General Hospital and Trauma Center, 1001 Potrero Avenue, 3D 5, San Francisco, CA 94110, USA Electronic address
Clin Geriatr Med 30:117-31. 2014..This article explores the evidence for screening and surveillance in the elderly, and addresses key challenges unique to this population. ..
- Durability of infliximab dose intensification in Crohn's diseaseKirk K Lin
Division of Gastroenterology, Department of Internal Medicine, University of California at San Francisco, San Francisco, CA, USA
Dig Dis Sci 57:1013-9. 2012..Dose intensification is a common approach to treat Crohn's disease (CD) patients who lose response to infliximab maintenance therapy. Few studies have reported upon its long-term efficacy or predictors of response...
- Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studiesFernando S Velayos
Division of Gastroenterology and UCSF Center for Colitis and Crohn s Disease, University of California, San Francisco, California 94143, USA
Am J Gastroenterol 100:1345-53. 2005..We performed a systematic review with metaanalysis of observational studies evaluating the association between 5-ASA use and colorectal cancer (CRC) or dysplasia among patients with ulcerative colitis...
- Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelinesFernando S Velayos
Division of Gastroenterology and Colorectal Cancer Prevention Program, University of California, San Francisco, CA, USA
Am J Gastroenterol 100:1143-9. 2005..We sought to determine the rate of MSI in adenomas removed from individuals under 40 yr of age over a 5-yr period in a university general gastroenterology practice...
- Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitisGary R Lichtenstein
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Rev Gastroenterol Disord 8:21-30; quiz 31-2. 2008..Novel formulations of mesalamine and newly devised, high-dose regimens offer additional therapeutic options and may lead to improved treatment adherence, longer-lasting periods of remission, and enhanced patient well-being...
- Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, MinnesotaTine Jess
Department of Medical Gastroenterology, Herlev University Hospital, Herlev, Denmark
Inflamm Bowel Dis 12:669-76. 2006....
- Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, MinnesotaTine Jess
Department of Medical Gastroenterology, Herlev University Hospital, Herlev, Denmark
Gastroenterology 130:1039-46. 2006..We estimated the risk for small-bowel and colorectal cancer in a population-based cohort of 692 inflammatory bowel disease patients from Olmsted County, Minnesota, from 1940 to 2001...